Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Work In Process (2016 - 2021)

Guided Therapeutics (GTHP) has disclosed Work In Process for 8 consecutive years, with $80000.0 as the latest value for Q1 2021.

  • Quarterly Work In Process fell 1.23% to $80000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $80000.0 through Mar 2021, down 1.23% year-over-year, with the annual reading at $80000.0 for FY2020, 1.23% down from the prior year.
  • Work In Process hit $80000.0 in Q1 2021 for Guided Therapeutics, roughly flat from $80000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $115000.0 in Q1 2017 to a low of $80000.0 in Q3 2020.
  • Historically, Work In Process has averaged $85000.0 across 5 years, with a median of $81000.0 in 2018.
  • Biggest five-year swings in Work In Process: plummeted 69.37% in 2017 and later changed 0.0% in 2019.
  • Year by year, Work In Process stood at $82000.0 in 2017, then decreased by 1.22% to $81000.0 in 2018, then changed by 0.0% to $81000.0 in 2019, then fell by 1.23% to $80000.0 in 2020, then changed by 0.0% to $80000.0 in 2021.
  • Business Quant data shows Work In Process for GTHP at $80000.0 in Q1 2021, $80000.0 in Q4 2020, and $80000.0 in Q3 2020.